GoldenGolden
Novacyt Group

Novacyt Group

The Novacyt Group is a diagnostics company with products and services in cancer and infectious disease areas

The Novacyt Group is a diagnostics company with products and services in cancer and infectious disease areas. The company engages in product development, commercialisation, contract design and manufacturing. Novacyte sells diagnostics products used in liquid based cytology (LBC), oncology, microbiology, haematology and serology. Divisions of the company include Microgen Bioproducts, which manufactures and distributes microbiology diagnostic products for clinical and food laboratories; LAB 21 Healthcare, which manufactures and supplies reagents and tests for IVD and blood grouping; Primer Design is their molecular diagnostics division which provides custom quantitative PCR (qPCR, also known as real time PCR, RT-PCR) assay development services.

Primerdesign developed a COVID-19 diagnostic test and in March, 2020 announced that it had increased manufacturing capacity to support production of 2 million COVID-19 tests per month. Novacyt is seeking FDA, Emergency Use Approval (EUA). A favourable performance assessment by Public Health England (PHE) has been reported. The test is part of the Genesig product line and is a real time PCR (RT-PCR) test that is CE-IVD marked for in vitro diagnostics in Europe.

Timeline

December 2014
Novacyt Group raises a $3,600,000 venture round from Alto Invest.
May 2012
Novacyt Group raises a $1,700,000 venture round.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.